BioCentury
ARTICLE | Company News

Aposense, Roche deal

November 15, 2010 8:00 AM UTC

Roche received a non-exclusive license to use Aposense's EarliTest technology in Roche's oncology development. Roche will use EarliTest, which comprises a ML-10 apoptosis imaging agent, to monitor tum...